Literature DB >> 29510807

Feasibility and safety of outpatient breast cancer surgery.

Helle Molter Duriaud1, Niels Kroman, Henrik Kehlet.   

Abstract

INTRODUCTION: Improvement in perioperative care programmes has facilitated post-operative recovery and use of short-term or outpatient procedures. The aim of this study was to assess the feasibility and safety of an outpatient breast cancer programme in patients referred to a large breast cancer unit.
METHODS: After an introduction period involving 554 consecutive patients, all patients operated from 1 November 2015 to 30 June 2016 (a total 483 patients) were treated with multimodal oral analgesia, preoperative high-dose glucocorticoids and no routine use of drains. Planned inpatient surgery included patients with mastectomy > 70 years, < 8 h in post-operative observation and < 2 h of observation after mobilisation.
RESULTS: Of the 382 patients who were planned for outpatient surgery (79%), 90% received surgery in an outpatient setup. Among the 101 patients (21%) who were planned for inpatient surgery, 17% returned home on the day of surgery. Consequently, the overall outpatient rate was 72% and the overall mean length of stay was 0.3 days, ranging from 0.1 days for breast-conserving surgery to 0.8 days for mastectomy. About 2% were readmitted within < 30 days, mostly due to wound problems.

Conclusion: Outpatient breast cancer surgery is feasible and safe in most patients in a socialised healthcare system. FUNDING: none. TRIAL REGISTRATION: not relevant.
. Articles published in the Danish Medical Journal are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Entities:  

Mesh:

Year:  2018        PMID: 29510807

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  4 in total

1.  Enhanced REVENUE After Surgery? A Cost-Standardized Enhanced Recovery Pathway for Mastectomy Decreases Length of Stay.

Authors:  Robert S Ackerman; Michael Hirschi; Brandon Alford; Trip Evans; John V Kiluk; Sephalie Y Patel
Journal:  World J Surg       Date:  2019-03       Impact factor: 3.352

2.  Mastectomy and Prepectoral Reconstruction in an Ambulatory Surgery Center Reduces Major Infectious Complication Rates.

Authors:  Jean-Claude Schwartz
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-07-15

3.  The Quest for Outpatient Mastectomy in COVID-19 Era: Barriers and Facilitators.

Authors:  L J van Zeelst; R Derksen; C H W Wijers; J Hegeman; R Berry; J H W de Wilt; L J A Strobbe
Journal:  Breast J       Date:  2022-06-01       Impact factor: 2.269

4.  Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency.

Authors:  Gianluca Vanni; Marco Pellicciaro; Marco Materazzo; Mario Dauri; Rolando Maria D'angelillo; Chiara Buonomo; Adriano De Majo; Chiara Pistolese; Ilaria Portarena; Alessandro Mauriello; Francesca Servadei; Erica Giacobbi; Agostino Chiaravalloti; Oreste Claudio Buonomo
Journal:  Breast Cancer       Date:  2020-07-30       Impact factor: 4.239

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.